Not applicableUnknownNCT01153191What this trial is testingEffectiveness for Interventions to Minimize Surgical Site InfectionsWho this might be right forInfections Dallas VA Medical Center 120
Early research (Phase 1)Looking for participantsNCT05176483What this trial is testingStudy of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid TumorsWho this might be right forRenal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more Exelixis 1,314
Not applicableStudy completedNCT06856590What this trial is testingZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin ReactionWho this might be right forHand-Foot Skin Reaction (HFSR) Gazi University 150
Not applicableLooking for participantsNCT04854213What this trial is testingPRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)Who this might be right forColorectal Cancer Metastatic National Cancer Institute, Naples 25
Not applicableWithdrawnNCT02151123What this trial is testingMetabiomics Colon Cancer Clinical Research StudyWho this might be right forColonic Neoplasms Metabiomics Corp
Testing effectiveness (Phase 2)Looking for participantsNCT07140679What this trial is testingImmunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon CancerWho this might be right forLocalized Colon CarcinomaStage IIB Colon Cancer AJCC v8Stage IIC Colon Cancer AJCC v8+1 more Emory University 40
Not applicableUnknownNCT03175146What this trial is testingSee Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver SafelyWho this might be right forColonic NeoplasmsNeoplasm Metastasis AHS Cancer Control Alberta 30
Testing effectiveness (Phase 2)Study completedNCT00002842What this trial is testingLiver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer City of Hope Medical Center 49
Testing effectiveness (Phase 2)Study completedNCT00514761What this trial is testingPhase II Efficacy Study of AZD6244 in Colorectal CancerWho this might be right forMetastatic Colorectal Cancer AstraZeneca 64
Testing effectiveness (Phase 2)Study completedNCT03227926What this trial is testingRechallenge With Panitumumab Driven by RAS Dynamic of ResistanceWho this might be right forColorectal Cancer Fondazione del Piemonte per l'Oncologia 32
Not applicableStudy completedNCT05034185What this trial is testingReal-World Validation of an Artificial Intelligence Characterization Support (CADx) SystemWho this might be right forColonic PolypColonic NeoplasmsColonic Dysplasia Changi General Hospital 450
Not applicableStudy completedNCT00572143What this trial is testingFollow-up After Surgery for Colon Cancer. General Practice vs. Surgical-based Follow-up?Who this might be right forColon Cancer University Hospital of North Norway 180
Early research (Phase 1)Ended earlyNCT02910843What this trial is testingNeoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal CancerWho this might be right forRectal Cancer Swiss Cancer Institute 25
Not applicableLooking for participantsNCT07024225What this trial is testingColorectal Cancers :A Retrospective StudyWho this might be right forColorectal Cancer Sohag University 100
Very early researchEnded earlyNCT00835679What this trial is testingCetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by SurgeryWho this might be right forLiver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+6 more National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT03666442What this trial is testingEarly Evaluation of Chemosensitivity for Low/Intermediated-risk Mid-low Stage II/III Rectal CancerWho this might be right forRectal Cancer West China Hospital 61
Large-scale testing (Phase 3)Ended earlyNCT05223673What this trial is testingPhase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Institut de Recherches Internationales Servier 7
Not applicableStudy completedNCT04532515What this trial is testingSeal-G / Seal-G MIST StudyWho this might be right forColon CancerGastrointestinal Cancer Advanced Medical Solutions Ltd. 160
Testing effectiveness (Phase 2)Study completedNCT04271813What this trial is testingAnlotinib Plus Sintilimab as First-line Treatment for Patients With Advanced Colorectal Cancer (APICAL-CRC)Who this might be right forColorectal CancerImmunotherapyAnlotinib+3 more Shanghai Changzheng Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT01060423What this trial is testingTACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal CancerWho this might be right forColorectal Cancer Hans-Joachim Schmoll, MD 8